Beam Therapeutics Inc. — Director's Dealing 2021

Jan 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2021-01-10

Reporting Person: Walsh Kathleen E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-10	Stock Option (Right to Buy)	$101.67	A	11609	Acquired	2031-01-09	Common Stock (11609)	Direct

Footnotes

F1: The option vests as to one-third of the shares subject to the option on the first anniversary of the date of grant, January 10, 2021 and in equal monthly installments as to the remainder of the shares for two years thereafter.